Review Article

Controversies in the Management and Followup of Differentiated Thyroid Cancer: Beyond the Guidelines

Table 2

Follow-up strategy based on risk groups (adapted from [4]).

Initial estimate of risk of recurrence first 2 years of followup incomplete response

Suppressed TgLow risk
Q 6 months
Intermediate risk
Q 6 months
High risk
Q 6 months
Stimulated TgNot required<10 ng/mL>10 ng/mL
Neck ultrasoundQ year 2Q year 2Q year 2
Diagnostic RAI WBSNot required1-2 years1-2 years
Cross-sectional imaging (MRI, CT)Not requiredNot requiredIf Tg elevated or high clinical suspicion

Secondary risk stratification response to therapy assessment

Ongoing followupYearly physical examination, yearly suppressed TgYearly physical examination, yearly suppressed Tg, stimulated Tg to document undetectable Tg on suppression,
continued observation/assessment of indeterminate structural abnormalities for at least another 2-3 years
Consider additional cross-sectional imaging, possibly FDG PET scan and the need for additional therapy